Breaking News
Get 50% Off 0
NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔 Read more
Close

Gam Multistock - Health Innovation Equity Usd E (0P0000AAZC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GAM Multistock - Health Innovation Equity USD E historical data, for real-time data please try another search
359.260 -0.010    -0.00%
21/07 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Fund
Market:  Italy
Issuer:  GAM (Luxembourg) SA
ISIN:  LU0329427503 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 69.84M
GAM Multistock - Health Innovation Equity USD E 359.260 -0.010 -0.00%

Gam Multistock - Health Innovation Equity Usd E Overview

 
On this page you'll find an in-depth profile of Gam Multistock - Health Innovation Equity Usd E. Learn about the key management, total assets, investment strategy and contact information of 0P0000AAZC among other information.
Category

Sector Equity Healthcare

Total Assets

69.84M

Expenses

2.55%

Inception Date

Jan 31, 2008

Investment Strategy

The investment objective in relation to the fund is to achieve long-term capital growth by investing at least 70% of the assets of HEALTH INNOVATION EQUITY in a portfolio of carefully-selected shares and other equity securities of companies that develop, produce or sell products, technologies, methods, procedures and/or services in the sectors of health care, pharmaceuticals, medical technology, biotechnology or biological sciences world-wide, which generate the best part of their profit through financing of these sectors, most of their shares are invested in these companies and/or most of their products and services offered are in these sectors. Further, their registered office or the major part of the business activity is in recognised countries.

Contact Information

Address 25, Grand Rue
Luxembourg, L-1661
Luxembourg
Phone +41 58 426 6000

Top Executives

Name Title Since Until
Christophe Eggmann - 2010 2022
Mirjam Heeb - 2015 2019
Nathalie Flury - 2008 2014
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000AAZC Comments

Write your thoughts about Gam Multistock - Health Innovation Equity Usd E
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email